Krishna Polu, Commit Biologics CEO

Dan­ish biotech nabs No­vo Hold­ings sup­port in seed round for com­ple­ment plat­form

No­vo Hold­ings is pitch­ing in to Com­mit Bi­o­log­ics’ seed fund­ing for its re­search on “su­per­charg­ing” an­ti­bod­ies to turn on the com­ple­ment sys­tem, an ap­proach that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.